Association of a neuronal nitric oxide synthase gene polymorphism with levodopa-induced dyskinesia in Parkinson's disease.

doi:10.1016/j.niox.2017.06.004

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Association of a neuronal nitric oxide synthase gene polymorphism with levodopa-induced dyskinesia in Parkinson's disease.

Nitric oxide : biology and chemistry - 1 Apr 2018

Santos-Lobato Bruno Lopes, Borges Vanderci, Ferraz Henrique Ballalai, Mata Ignacio Fernandez, Zabetian Cyrus P, Tumas Vitor

Abstract excerpt

BACKGROUND: Levodopa-induced dyskinesia (LID) is a common complication of advanced Parkinson's disease (PD). PD physiopathology is associated with dopaminergic and non-dopaminergic pathways, including the nitric oxide system. The present study aims to examine the association of a neuronal nitric oxide synthase gene (NOS1) single nucleotide polymorphism (rs2682826) with LID in PD patients. METHODS AND RESULTS: We...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antiparkinson Agents

Share to Dyskinesias

Share to NOS1 gene

Share to Levodopa

Share to Nitric Oxide Synthase Type I

Share to Parkinson Disease

Share to Polymorphism, Single Nucleotide

Source

Open in PubMed

Identifiers

PMID: 28602747
DOI: 10.1016/j.niox.2017.06.004

Genes

NOS1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of a neuronal nitric oxide synthase gene polymorphism with levodopa-induced dyskinesia in Parkinson's disease.PMID 28602747Read ↗

Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson's disease.Semantic proximity Read ↗

Comprehensive association analysis of the NOS2A gene with Parkinson disease.Semantic proximity Read ↗

Nitric oxide synthase genes and their interactions with environmental factors in Parkinson's disease.Semantic proximity Read ↗

Association of Polymorphism of Neuronal Nitric Oxide Synthase Gene with Risk to Parkinson's Disease.Semantic proximity Read ↗

Neuronal nitric oxide synthase (nNOS, NOS1) rs693534 and rs7977109 variants and risk for restless legs syndrome.Semantic proximity Read ↗

NOS2A and the modulating effect of cigarette smoking in Parkinson's disease.Semantic proximity Read ↗

Influence of single nucleotide polymorphisms in COMT, MAO-A and BDNF genes on dyskinesias and levodopa use in Parkinson's disease.Semantic proximity Read ↗

Variants in the neuronal nitric oxide synthase (nNOS, NOS1) gene are associated with restless legs syndrome.Semantic proximity Read ↗

Association analysis of a neural nitric oxide synthase gene polymorphism and antipsychotics-induced tardive dyskinesia in Chinese schizophrenic patients.Semantic proximity Read ↗

Neuronal nitric oxide synthase (NOS1) and its adaptor, NOS1AP, as a genetic risk factors for psychiatric disorders.Semantic proximity Read ↗

Genotype and smoking history affect risk of levodopa-induced dyskinesias in Parkinson's disease.Semantic proximity Read ↗

Allelic association of the neuronal nitric oxide synthase (NOS1) gene with schizophrenia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.